Although impairments in adiponectin signaling are believed to confer mitochondrial toxicity within end-organs affected by longstanding diabetes, the precise molecular intermediates remain unknown, as do the differences across tissue-types. The gene discussed is ADIPOQ; the disease is diabetes mellitus.